Allergan launches generic version of AstraZeneca cholesterol tablet

Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Acorda and AstraZeneca claim victory over Mylan

21 March 2016 The US Court of Appeals for the Federal Circuit has rejected Mylan’s attempt to dismiss two patent lawsuits on the grounds of lack of personal jurisdiction.

Americas

FTC sues Endo over ‘pay-for-delay’ settlements

4 April 2016 The Federal Trade Commission has sued Endo Pharmaceuticals for allegedly violating competition laws by agreeing to so-called pay-for-delay settlements surrounding the launch of generic versions of two drugs.

Americas

AstraZeneca completes acquisition of Takeda’s respiratory business

5 May 2016 AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas

Acorda and AstraZeneca claim victory over Mylan

21 March 2016 The US Court of Appeals for the Federal Circuit has rejected Mylan’s attempt to dismiss two patent lawsuits on the grounds of lack of personal jurisdiction.

Americas

FTC sues Endo over ‘pay-for-delay’ settlements

Americas

AstraZeneca completes acquisition of Takeda’s respiratory business

5 May 2016 AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas

Acorda and AstraZeneca claim victory over Mylan

21 March 2016 The US Court of Appeals for the Federal Circuit has rejected Mylan’s attempt to dismiss two patent lawsuits on the grounds of lack of personal jurisdiction.

Americas

FTC sues Endo over ‘pay-for-delay’ settlements

Americas

AstraZeneca completes acquisition of Takeda’s respiratory business

5 May 2016 AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.